Pages that link to "Q2536586"
Jump to navigation
Jump to search
The following pages link to Antoni van Leeuwenhoekziekenhuis (Q2536586):
Displaying 50 items.
- Wubbo Ockels (Q944386) (← links)
- Marjanka K Schmidt (Q37372106) (← links)
- Ferhat Alkan (Q41195054) (← links)
- Astrid Fauster (Q55458032) (← links)
- Rick Lm Haas (Q57615233) (← links)
- Neo-adjuvant Pembrolizumab in Primary Stage IV Ovarian Cancer (Q58407764) (← links)
- Daniela S Thommen (Q58701244) (← links)
- Nivolumab, Ipilimumab and COX2-inhibition in Early Stage Colon Cancer: an Unbiased Approach for Signals of Sensitivity (Q58846075) (← links)
- Lenno Krenning (Q60737628) (← links)
- Study Evaluating the Safety, Pharmacokinetics (PK), Pharmacodynamics (PD), and Therapeutic Activity of Selicrelumab (RO7009789) With Vanucizumab or Bevacizumab in Participants With Metastatic Solid Tumors (Q61070971) (← links)
- Linda M Henricks (Q61822471) (← links)
- Catheter Ablation vs. Standard Conventional Treatment in Patients With LV Dysfunction and AF (Q61914651) (← links)
- Study to Assess the Non-inferiority of Pamorelin® 11,25mg SC Injected Versus Pamorelin® 11,25mg IM Injected in Patients Suffering From Advanced Prostate Cancer (PAMOJECT) (Q61924707) (← links)
- Neoadjuvant Chemotherapy in HER2 Positive Breast Cancer, TRAIN-2 (Q61969619) (← links)
- An Investigational Immuno-therapy Study to Assess the Safety, Tolerability and Effectiveness of Anti-LAG-3 With and Without Anti-PD-1 in the Treatment of Solid Tumors (Q61975539) (← links)
- Dose Individualization of Pemetrexed - IMPROVE-I (Q62024885) (← links)
- Dose Individualization of Pemetrexed - IMPROVE-III (Q62024942) (← links)
- Dose Individualization of Pemetrexed - IMPROVE-II (Q62024944) (← links)
- Daniel Peeper (Q62560307) (← links)
- Vinorelbine in Advanced BRAF-like Colon Cancer (Q62810829) (← links)
- Blinatumomab Added to Prephase and Consolidation Therapy in Precursor B-acute Lymphoblastic Leukemia in Adults. (Q62811927) (← links)
- ctDNA as a Biomarker for Treatment Response in HNSCC (Q62812134) (← links)
- CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes (Q63340041) (← links)
- M7824 Versus Pembrolizumab as a First-line (1L) Treatment in Participants With Programmed Death-ligand 1 (PD-L1) Expressing Advanced Non-small Cell Lung Cancer (NSCLC) (Q63394793) (← links)
- 18F-PD-L1 PET/CT in Nivolumab Treated Patients With NSCLC (Q63398934) (← links)
- Neoadjuvant Capecitabine, Oxaliplatin, Docetaxel and Atezolizumab in Resectable Gastric and GE-junction Cancer (PANDA) (Q63401172) (← links)
- "Wait-and-see" Policy for Complete Responders After Chemoradiotherapy for Rectal Cancer (Q63401498) (← links)
- Endocrine Therapy Plus CDK4/6 in First or Second Line for Hormone (SONIA) Receptor Positive Advanced Breast Cancer (Q63401675) (← links)
- Second and Third Look Laparoscopy in pT4 Colon Cancer Patients for Early Detection of Peritoneal Metastases (Q63401853) (← links)
- Monitoring MRI Changes Before and During Radiotherapy Treatment of Brain Tumors (Q63404113) (← links)
- Neo-Adjuvant Bladder Urothelial Carcinoma COmbination-immunotherapy (Q63405668) (← links)
- A Study of RO6958688 in Participants With Locally Advanced and/or Metastatic Carcinoembryonic Antigen Positive Solid Tumors (Q63571407) (← links)
- A Long Term Extension Study of Ixekizumab (LY2439821) in Participants With Axial Spondyloarthritis (Q63576351) (← links)
- Study of IMMU-132 in HR+/HER2- MBC (TROPICS-02) (Q63578572) (← links)
- Afatinib and Cetuximab in Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Positive Non-small-cell Lung Cancer (Q63596855) (← links)
- A Study of DCC-2618 vs Sunitinib in Advanced GIST Patients After Treatment With Imatinib (Q63597811) (← links)
- A Study of RO7198457 as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors (Q63811963) (← links)
- A Study Into the Effectivity and Safety of Firmagon, Prescribed for Treatment of Patients With Advanced Prostate Cancer (Q63818603) (← links)
- Standard Chemotherapy With of Without Axitinib in Malignant Mesothelioma (Q63819254) (← links)
- The Role of Surgery of the Primary Tumour in Patients With Synchronous Unresectable Metastases of Colorectal Cancer (Q63843020) (← links)
- Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy (Q64046651) (← links)
- GLORIA-AF Registry Program (Phase II/III - EU/EEA Member States) (Q64123586) (← links)
- A Randomized Phase 2 Study of Cemiplimab ± ISA101b in HPV16-Positive OPC (Q64189479) (← links)
- The Glucocorticoid Low-dose Outcome in RheumatoId Arthritis Study (Q64217511) (← links)
- Prospective Data Collection Initiative on Colorectal Cancer (Q64222741) (← links)
- Single Scope Staging of Lung Cancer With Endosonography (Q64350843) (← links)
- A Study to Evaluate Safety, Pharmacokinetics, and Efficacy of RO6895882 in Participants With Advanced and/or Metastatic Solid Tumors (Q64351684) (← links)
- Prediction of Everolimus-induced Interstitial Lung Disease (Q64352753) (← links)
- Comparing Two Palliative Schemes of Radiotherapy for Head and Neck Cancer (Q64375603) (← links)
- Brentuximab Vedotin Associated With Chemotherapy in Untreated Patients With Hodgkin Lymphoma. (Q64598704) (← links)